Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| LAMPERT MARK N | Other | 12 | $0 | $0 | 2020-12-22 |
| OrbiMed Israel GP Ltd. | 10% Owner | 1 | $0 | $2.23M | 2020-12-02 |
| Logos Global Management LP | 10% Owner | 9 | $2.34M | $345.5K | 2020-10-30 |
| Kuwahara Jon | See Remarks | 9 | $0 | $10.3K | 2020-09-11 |
| Gros David-Alexandre C | Chief Executive Officer | 1 | $0 | $0 | 2020-09-11 |
| McBride John S. | Director | 4 | $0 | $0 | 2020-09-11 |
| Katkin Keith | Director | 4 | $0 | $0 | 2020-09-11 |
| LYONS GARY A | Director | 4 | $0 | $0 | 2020-09-11 |
| FLESHER GREGORY J. | Chief Executive Officer | 10 | $589.0K | $28.5K | 2020-03-19 |
| TURKEL CATHERINE C. | President | 14 | $275.4K | $18.6K | 2020-03-19 |
| Chimovits Erez | Director, 10% Owner | 6 | $2.00M | $258.5K | 2020-01-14 |
| OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | 6 | $2.00M | $258.5K | 2020-01-14 |
| Cohen Cheryl | Director | 3 | $0 | $0 | 2019-07-11 |
| YOOK PAUL | 10% Owner | 1 | $0 | $540 | 2019-04-30 |
| Morrison Jodie Pope | Director | 1 | $0 | $0 | 2017-06-30 |
| OCAMPO CHRISTINE | See Remarks | 2 | $100.0K | $0 | 2017-05-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 11,776 | — | $0 | 52,145 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 273 | — | $0 | 0 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 1,757 | — | $0 | 6,758 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 9,169 | — | $0 | 39,693 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 35 | — | $0 | 0 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion deriv | 2020-12-22 | 2020-12-28 | 203 | — | $0 | 0 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 11,278 | — | $0 | 89,214 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 15,166 | — | $0 | 117,565 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 654,215 | — | $0 | 771,780 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 509,410 | — | $0 | 598,624 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 97,615 | — | $0 | 113,152 | SEC↗ |
| LAMPERT MARK N | Other | C Conversion | 2020-12-22 | 2020-12-28 | 1,944 | — | $0 | 15,537 | SEC↗ |
| OrbiMed Israel GP Ltd. | 10% Owner | S Sale | 2020-12-02 | 2020-12-04 | 103,200 | $21.60 | $2.23M | 73,650 | SEC↗ |
| Logos Global Management LP | 10% Owner | S Sale | 2020-10-30 | 2020-11-06 | 12,942 | $26.64 | $344.8K | 187,058 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 15,000 | $26.17 | $392.6K | 214,973 | SEC↗ |
| Logos Global Management LP | 10% Owner | S Sale | 2020-10-30 | 2020-11-06 | 27 | $27.02 | $730 | 199,973 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 12,942 | $25.88 | $334.9K | 200,000 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 9,098 | $25.55 | $232.5K | 224,071 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 15,000 | $26.48 | $397.2K | 200,000 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 4,000 | $25.97 | $103.9K | 185,000 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 31,000 | $24.53 | $760.4K | 181,000 | SEC↗ |
| Logos Global Management LP | 10% Owner | P Buy | 2020-10-30 | 2020-11-06 | 5,000 | $24.03 | $120.2K | 150,000 | SEC↗ |
| McBride John S. | Director | A Award deriv | 2020-09-11 | 2020-09-15 | 1,167 | — | $0 | 1,167 | SEC↗ |
| Katkin Keith | Director | A Award deriv | 2020-09-11 | 2020-09-15 | 5,907 | — | $0 | 5,907 | SEC↗ |
| Gros David-Alexandre C | Chief Executive Officer | A Award deriv | 2020-09-11 | 2020-09-15 | 18,278 | — | $0 | 18,278 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2020-09-11 | 2020-09-15 | 2,145 | — | $0 | 2,145 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2020-09-11 | 2020-09-15 | 1,167 | — | $0 | 1,167 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2020-03-19 | 2020-03-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award deriv | 2020-03-19 | 2020-03-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award deriv | 2020-03-19 | 2020-03-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | S Sale deriv | 2020-01-14 | 2020-02-25 | 646,204 | $0.20 | $129.2K | 0 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award deriv | 2019-09-26 | 2019-09-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award deriv | 2019-09-26 | 2019-09-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2019-09-26 | 2019-09-30 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Chimovits Erez | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Katkin Keith | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McBride John S. | Director | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | S Sale | 2019-05-21 | 2019-05-22 | 2,937 | $1.91 | $5.6K | 156,918 | SEC↗ |
| Kuwahara Jon | See Remarks | S Sale | 2019-05-21 | 2019-05-22 | 1,058 | $1.91 | $2.0K | 5,974 | SEC↗ |
| TURKEL CATHERINE C. | President | S Sale | 2019-05-21 | 2019-05-22 | 1,914 | $1.91 | $3.7K | 88,662 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | S Sale | 2019-05-20 | 2019-05-22 | 11,701 | $1.96 | $22.9K | 159,855 | SEC↗ |
| Kuwahara Jon | See Remarks | S Sale | 2019-05-20 | 2019-05-22 | 4,218 | $1.96 | $8.3K | 7,032 | SEC↗ |
| TURKEL CATHERINE C. | President | S Sale | 2019-05-20 | 2019-05-22 | 7,623 | $1.96 | $14.9K | 90,576 | SEC↗ |
| Chimovits Erez | Director | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| Chimovits Erez | Director | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy deriv | 2019-05-02 | 2019-05-06 | 646,204 | — | $0 | 646,204 | SEC↗ |
| Chimovits Erez | Director | P Buy | 2019-05-02 | 2019-05-06 | 646,204 | $3.10 | $2.00M | 3,183,314 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy | 2019-05-02 | 2019-05-06 | 646,204 | $3.10 | $2.00M | 3,183,314 | SEC↗ |
| YOOK PAUL | 10% Owner | S Sale | 2019-04-30 | 2019-05-02 | 200 | $2.70 | $540 | 1,065,867 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2019-03-14 | 2019-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award deriv | 2019-03-14 | 2019-03-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award deriv | 2019-03-14 | 2019-03-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award | 2019-03-14 | 2019-03-18 | 25,000 | — | $0 | 171,556 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award | 2019-03-14 | 2019-03-18 | 20,000 | — | $0 | 98,199 | SEC↗ |
| TURKEL CATHERINE C. | President | P Buy | 2018-09-12 | 2018-09-13 | 16,632 | $5.02 | $83.5K | 78,199 | SEC↗ |
| TURKEL CATHERINE C. | President | P Buy | 2018-09-11 | 2018-09-13 | 17,048 | $4.56 | $77.7K | 61,567 | SEC↗ |
| TURKEL CATHERINE C. | President | P Buy | 2018-09-05 | 2018-09-07 | 805 | $3.97 | $3.2K | 805 | SEC↗ |
| McBride John S. | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| Katkin Keith | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award deriv | 2018-03-13 | 2018-03-15 | 24,000 | — | $0 | 24,000 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award deriv | 2018-03-13 | 2018-03-15 | 56,500 | — | $0 | 56,500 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2018-03-13 | 2018-03-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award | 2018-03-13 | 2018-03-15 | 20,000 | — | $0 | 44,519 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award | 2018-03-13 | 2018-03-15 | 30,700 | — | $0 | 146,556 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award | 2018-03-13 | 2018-03-15 | 11,250 | — | $0 | 11,250 | SEC↗ |
| TURKEL CATHERINE C. | President | A Award deriv | 2017-11-06 | 2017-11-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Kuwahara Jon | See Remarks | A Award deriv | 2017-07-10 | 2017-07-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Katkin Keith | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Morrison Jodie Pope | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Cohen Cheryl | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| McBride John S. | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| OCAMPO CHRISTINE | See Remarks | A Award deriv | 2017-05-24 | 2017-05-26 | 52,500 | — | $0 | 52,500 | SEC↗ |
| TURKEL CATHERINE C. | Chief Development Officer | A Award deriv | 2017-05-24 | 2017-05-26 | 52,500 | — | $0 | 52,500 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | A Award deriv | 2017-05-24 | 2017-05-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| OCAMPO CHRISTINE | See Remarks | P Buy | 2017-05-10 | 2017-05-11 | 10,010 | $9.99 | $100.0K | 21,590 | SEC↗ |
| TURKEL CATHERINE C. | Chief Development Officer | P Buy | 2017-05-10 | 2017-05-11 | 11,111 | $9.99 | $111.0K | 24,519 | SEC↗ |
| FLESHER GREGORY J. | Chief Executive Officer | P Buy | 2017-05-10 | 2017-05-11 | 58,959 | $9.99 | $589.0K | 115,856 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | A Award | 2017-05-09 | 2017-05-11 | 2,537,110 | — | $0 | 2,537,110 | SEC↗ |